2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
Gerds A, Gotlib J, Bose P, Deininger M, Dunbar A, Elshoury A, George T, Gojo I, Gundabolu K, Hexner E, Hobbs G, Jain T, Jamieson C, Kuykendall A, McMahon B, Mohan S, Oehler V, Oh S, Pardanani A, Podoltsev N, Ranheim E, Rein L, Salit R, Snyder D, Stein B, Talpaz M, Thota S, Vachhani P, Wadleigh M, Walsh K, Ward D, Bergman M, Sundar H. Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2020, 18: 1248-1269. PMID: 32886902, DOI: 10.6004/jnccn.2020.0042.Peer-Reviewed Original ResearchConceptsMyeloid/lymphoid neoplasmsWHO classificationMLN-EoFusion geneEosinophilic disordersNCCN Clinical Practice GuidelinesRearrangement of PDGFRATyrosine kinaseABL1 rearrangementsClinical practice guidelinesLymphoid neoplasmsNCCN GuidelinesDysregulated tyrosine kinasePeripheral bloodPCM1-JAK2Organ damageABL1 geneNonneoplastic conditionsNeoplasmsEosinophiliaHeterogeneous groupFLT3Practice guidelinesNCCNABL1
2010
Overview of the Lymphoid Neoplasms
Podoltsev N, Lacy J, Vose J. Overview of the Lymphoid Neoplasms. 2010, 3-39. DOI: 10.1007/978-1-4419-7668-0_1.Peer-Reviewed Original ResearchNon-Hodgkin lymphomaHodgkin's lymphomaPathogenesis of lymphomaHistologic featuresEtiologic factorsCommon subtypeWHO classificationTreatment outcomesCell neoplasmsClinical aspectsClinical groupingLymphoid malignanciesLymphoma pathogenesisLymphoid cellsLymphoid neoplasmsNormal lymphocytesLymphomaImmune systemDistinct subtypesNeoplasmsLymphocyte developmentSecond portionPathogenesisSubtypesGenetic events